This Solicitation opportunity from Department Of Defense was posted on May 28, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
DIAZEPAM INJECTION
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
The contract pertains to the procurement of Diazepam Injection, identified by NSN/Part Number 6505-01-505-3476, with a requested quantity of 10 units. This solicitation, numbered SPE2DP-26-T-3573, was posted by the Defense Logistics Agency under the Department of Defense on May 28, 2026. Interested parties were given until June 3, 2026, to respond to the solicitation. The contract solicitation type is for federal acquisition purposes, with no specific set-aside or industry classification indicated. The contract’s place of performance and office address details are not specified, reflecting a centralized federal procurement process. The solicitation is accessible through the Defense Logistics Agency’s procurement portal, allowing potential vendors within the federal contracting space to submit offers for the supply of Diazepam Injection. This contract underscores the Department of Defense’s ongoing need for controlled pharmaceutical products to support its operations.
General Info
Agency
NAICS
Place of Performance
USASet-Aside
Timeline
Submission Closed
Organization & Contact Information
Full Description
More opportunities from Department Of Defense → Defense Logistics Agency
Same awarding agency
Find Active Opportunities Like This
Get AI-powered intelligence on the opportunities still open
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 650+ contractors already using CLEATUS
